Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 3,967 recruiting studies in this area right now.
By phase
- Not applicable2,544
- Phase 2357
- Phase 4303
- Phase 1288
- Phase 3283
- Phase 1/Phase 2133
- Phase 2/Phase 359
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris69
- University of California, San Francisco39
- Johns Hopkins University30
- National Cancer Institute (NCI)28
- Hospices Civils de Lyon27
- Columbia University24
- University of Oxford23
- University of Washington23
- University of Alabama at Birmingham22
Where studies are running
- California234
- Maryland142
- Alabama92
- New York73
- Florida72
- Texas62
- Massachusetts57
- Arizona48
- Pennsylvania43
- Illinois41
Recruiting studies3,967 total
- NCT06798415RecruitingPhase 2
Metronidazole injections for leishmaniasis skin sores
This study tests if an injection of the antibiotic metronidazole directly into skin sores can help heal leishmaniasis, a parasite infection from sandfly bites. It's for people with fewer than seven sores.
BaghdadAges 18–80 - NCT06776263Recruiting
Breathing problems after COVID-19 study
This study looks at people who have ongoing breathing issues after a COVID-19 infection. It tests a simple questionnaire to see if you have dysfunctional breathing (abnormal breathing patterns) and may help guide treatment.
Stockholm, SolnaAges 18 years+ - NCT06827249Recruiting
Testing peginterferon for RSV lung infection in young children
This trial tests a medication called peginterferon to treat RSV bronchiolitis (a lung infection causing wheezing and breathing trouble) in children ages 6 months to 2 years. It aims to see if the drug helps them recover faster.
Wuhan, HubeiAges 6 months–2 years - NCT06826820Recruiting
Fertility and infection study
This study looks at how infections and inflammation might affect fertility in women. It aims to better understand these connections to help improve treatment and care.
GrazAges 18 years+ - NCT06625268Recruiting
Quick Test for Urinary Tract Infections in Women
This study tests a quick, in-clinic test for women with suspected urinary tract infections. The goal is to see if the test can accurately find bacteria and give fast results to help your doctor choose the right treatment.
Würzburg, BavariaAges 18 years+ - NCT07397689Recruiting
Early Sepsis Detection Tool for Children
This trial checks if a new tool can help doctors spot sepsis early in children. If your child is under 18, had a blood culture, and received strong antibiotics within the first day in the hospital, they may qualify.
ShanghaiAges Up to 18 years - NCT07397403RecruitingPhase 4
Doxycycline to prevent STIs in men who have sex with men
This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.
Sathorn, BangkokAges 3 weeks–2 months - NCT07390474RecruitingPhase 1
HIV vaccine safety and immune response study for healthy adults
This study tests two experimental mRNA-based HIV vaccines to see if they are safe and create an immune response. It is for healthy adults aged 18 to 55 who do not have HIV.
Atlanta, GeorgiaAges 18–55 - NCT07390955RecruitingPhase 1
Safety study of three anti-HIV antibodies in healthy adults
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
Birmingham, AlabamaAges 18–55 - NCT06829940Recruiting
Baduanjin exercise for long COVID fatigue
This trial tests whether Baduanjin, a gentle mind-body exercise, can help people under 50 with long-standing chronic fatigue that's worse after COVID-19. It aims to see if this safe, low-impact practice improves energy and daily life without needing extra treatments.
CairoAges 18–50 - NCT07393659RecruitingPhase 3
Continued access to HIV treatment after a parent study
This study lets people who finished an earlier HIV treatment study keep getting the same medicine while a new trial is set up. It helps ensure you don't have a gap in your treatment.
Durban, KwaZulu-NatalAges Any age - NCT07395739RecruitingPhase 1
Safety and immune response test of a new meningitis B vaccine
This trial tests a new vaccine called DX-104 to see if it is safe and helps the body fight meningitis B. Healthy adults aged 18-50 can join to help find a better way to prevent this infection.
Perth, Western AustraliaAges 18–50 - NCT07392372RecruitingPhase 1
Testing the safety of BNT351 in people with and without HIV
This trial tests a new antibody called BNT351 to see if it is safe and how it affects the immune system. It is for adults who either do not have HIV, or have HIV and are not currently on HIV medications.
Chicago, IllinoisAges 18–65 - NCT07391735Recruiting
Tracking Wound Healing After Surgery With an App
This study uses a smartphone app called MyHealthPal to track wound healing after certain spine or pain management surgeries. If you are getting a spinal cord stimulator or pain pump procedure, you may be able to join and help improve how recovery is monitored.
Chestnut Hill, MassachusettsAges 18 years+ - NCT07397455RecruitingPhase 1
COVID-19 Omicron Human Challenge Study
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
LondonAges 18–50 - NCT07395596RecruitingPhase 4
Remimazolam for Bronchoscopy in High-Risk Patients
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
Hangzhou, ZhejiangAges 18 years+ - NCT07394257Recruiting
Antibiotic injection for hard-to-treat bacterial eye infection
This trial tests if an antibiotic injection directly into the cornea can help when standard eye drops are not working for a stubborn bacterial eye infection.
MinyaAges 20 years+ - NCT07396428Recruiting
Reducing antibiotic use for respiratory infections in Swiss primary care
This study tests whether following a national guideline for treating common respiratory infections (like colds, sore throats, or bronchitis) can help doctors in Switzerland prescribe fewer antibiotics. It focuses on primary care physicians and clinics in certain cantons who are willing to participate in surveys and interviews.
Lausanne, Canton of VaudAges Any age - NCT07392684Recruiting
Improving blood culture collection in adults
This trial looks at how to improve the way blood cultures are collected and processed. It involves staff members who collect adult blood cultures at Gloucestershire Hospitals NHS Foundation Trust, using data from samples taken between February 2023 and April 2024.
Gloucester, GloucestershireAges Any age - NCT07395297Recruiting
Airway clearance therapy for ICU lung infections
This trial tests a new airway clearance device in ICU patients with pneumonia. It may help clear mucus from your lungs and improve breathing without needing a breathing tube.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07395518Enrolling by invitation
Drain placement in c-section for women with thick belly fat
This trial tests if placing a small drain under the skin during a cesarean section reduces surgical site infections in women with a belly fat thickness of 4 cm or more. It may help prevent infections and improve recovery.
Chon Buri, Changwat Chon BuriAges 18 years+ - NCT07391995Recruiting
New test for germs in diabetic foot bone infections
This study tests a new device that quickly identifies the germs in foot wounds of people with diabetes and bone infections. It may help doctors choose the right antibiotic faster.
Nîmes, GardAges Any age - NCT05417932RecruitingPhase 1/Phase 2
Cell therapy for hepatitis B–related liver cancer
This Phase 1/2 study tests a lab-made cell treatment (SCG101) for people with hepatitis B–related liver cancer who have already had standard treatments. It aims to shrink tumors and improve outcomes in carefully selected patients.
New York, New YorkAges 18–70 - NCT04256798RecruitingPhase 3
Respiratory care after high-risk abdominal surgery
This trial looks at a breathing-focused care plan given around the time of major abdominal surgery to improve recovery and outcomes. You may be eligible if you’re having a large midline abdominal incision and can be followed after surgery.
Botucatu, São PauloAges 10–100
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 3,967 recruiting infectious disease studies from the U.S. registry right now, out of 6,571 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.